| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |